ResMed Inc.
MX ˙ BMV ˙ US7611521078
SecurityMX:RMD / ResMed Inc.
InstitutionOppenheimer Asset Management Inc.
Latest Disclosed Ownership1,714 shares
Latest Disclosed Value $ 384,758
Oppenheimer Asset Management Inc. reports 1.42% increase in ownership of RMD / ResMed Inc.

On April 23, 2026 - Oppenheimer Asset Management Inc. filed a 13F-HR form disclosing ownership of 1,714 shares of ResMed Inc. (MX:RMD) valued at $384,758 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 1,690 shares of ResMed Inc.. This represents a change in shares of 1.42% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-23 2026-03-31 13F RESMED COM 761152107 1,714 24 1.42 385 -5.65 0.0011
2026-02-02 2025-12-31 13F RESMED COM 761152107 1,690 -137 -7.50 407 -18.60 0.0012
2025-11-06 2025-09-30 13F RESMED COM 761152107 1,827 -175 -8.74 500 -3.10 0.0055
2025-07-31 2025-06-30 13F RESMED COM 761152107 2,002 -6,937 -77.60 517 -74.20 0.0059
2025-04-23 2025-03-31 13F RESMED COM 761152107 8,939 -741 -7.65 2,001 -9.62 0.0248
2025-02-05 2024-12-31 13F RESMED COM 761152107 9,680 -309 -3.09 2,214 -9.23 0.0269
2024-11-05 2024-09-30 13F RESMED COM 761152107 9,989 -188 -1.85 2,439 25.15 0.0294
2024-08-08 2024-06-30 13F RESMED COM 761152107 10,177 674 7.09 1,948 3.56 0.0249
2024-05-07 2024-03-31 13F RESMED COM 761152107 9,503 -572 -5.68 1,882 8.54 0.0276
2024-02-13 2023-12-31 13F RESMED COM 761152107 10,075 537 5.63 1,733 22.91 0.0241
2023-11-08 2023-09-30 13F RESMED COM 761152107 9,538 -88 -0.91 1,410 -32.95 0.0216
2023-08-03 2023-06-30 13F RESMED COM 761152107 9,626 -107 -1.10 2,103 -1.31 0.0309
2023-05-10 2023-03-31 13F RESMED COM 761152107 9,733 -664 -6.39 2,131 -1.48 0.0328
2023-02-07 2022-12-31 13F RESMED COM 761152107 10,397 -67 -0.64 2,164 -5.30 0.0348
2022-11-14 2022-09-30 13F RESMED COM 761152107 10,464 -627 -5.65 2,284 -1.76 0.0403
2022-08-08 2022-06-30 13F RESMED COM 761152107 11,091 -17 -0.15 2,325 -13.70 0.0390
2022-05-12 2022-03-31 13F RESMED COM 761152107 11,108 -252 -2.22 2,694 -8.99 0.0382
2022-02-02 2021-12-31 13F RESMED COM 761152107 11,360 92 0.82 2,960 -0.34 0.0392
2021-11-12 2021-09-30 13F RESMED COM 761152107 11,268 -378 -3.25 2,970 3.45 0.0422
2021-08-03 2021-06-30 13F RESMED COM 761152107 11,646 129 1.12 2,871 28.46 0.0409
2021-05-17 2021-03-31 13F RESMED COM 761152107 11,517 464 4.20 2,235 -4.89 0.0346
2021-02-11 2020-12-31 13F RESMED COM 761152107 11,053 -281 -2.48 2,350 20.95 0.0392
2020-11-13 2020-09-30 13F RESMED COM 761152107 11,334 -169 -1.47 1,943 -12.04 0.0377
2020-08-11 2020-06-30 13F RESMED COM 761152107 11,503 -1,946 -14.47 2,209 11.51 0.0456
2020-05-08 2020-03-31 13F RESMED COM 761152107 13,449 -412 -2.97 1,981 -7.77 0.0487
2020-02-07 2019-12-31 13F RESMED COM 761152107 13,861 -169 -1.20 2,148 13.29 0.0454
2019-10-31 2019-09-30 13F RESMED COM 761152107 14,030 -466 -3.21 1,896 7.18 0.0421
2019-08-09 2019-06-30 13F RESMED COM 761152107 14,496 187 1.31 1,769 18.96 0.0391
2019-04-24 2019-03-31 13F RESMED COM 761152107 14,309 60 0.42 1,487 -8.32 0.0334
2019-01-30 2018-12-31 13F RESMED COM 761152107 14,249 -527 -3.57 1,622 -4.87 0.0402
2018-10-26 2018-09-30 13F RESMED COM 761152107 14,776 -345 -2.28 1,705 8.88 0.0378
2018-08-10 2018-06-30 13F RESMED COM 761152107 15,121 -1,123 -6.91 1,566 -2.12 0.0383
2018-05-09 2018-03-31 13F RESMED COM 761152107 16,244 -1,647 -9.21 1,600 16.19 0.0401
2018-02-07 2017-12-31 13F RESMED COM 761152107 17,891 0 0.00 1,377 0.00 0.0365
2017-11-14 2017-09-30 13F RESMED COM 761152107 17,891 85 0.48 1,377 -0.65 0.0358
2017-08-09 2017-06-30 13F RESMED COM 761152107 17,806 -312 -1.72 1,386 6.29 0.0383
2017-05-15 2017-03-31 13F RESMED COM 761152107 18,118 18,118 1,304 0.0371
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.